Rheumatoid Arthritis Recruiting Phase 2 Trials for Methotrexate (DB00563)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03589833Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RATreatment
NCT03233230Phase IIb Study of Evobrutinib in Subjects With Rheumatoid ArthritisTreatment
NCT02467504Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid ArthritisTreatment
NCT02270632A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTXTreatment